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Initial sites of hepadnavirus integration into host genome in
human hepatocytes and in the woodchuck model of hepatitis
B-associated hepatocellular carcinoma
R Chauhan, ND Churchill, PM Mulrooney-Cousins and TI Michalak
Hepatitis B virus (HBV) and the closely related woodchuck hepatitis virus (WHV) are potent carcinogens that trigger development of
primary hepatocellular carcinoma (HCC). The initial sites of hepadnavirus–host genome integration, their diversity and kinetics of
formation can be central to virus persistence and the initiation and progression of HCC. To recognize the nature of the very early
virus–host interactions, we explored de novo infection of human hepatocyte-like HepaRG cells with authentic HBV and naive
woodchucks with WHV. HepaRG were analyzed from several minutes post exposure to HBV onwards, whereas woodchuck liver
biopsies at 1 or 3 h and 6 weeks post infection with WHV. Inverse PCR and clonal sequencing of the amplicons were applied to
identify virus–host genomic junctions. HBV and WHV DNA and their replication intermediates became detectable in one hour after
virus exposure. Concomitantly, HBV DNA integration into various host genes was detected. Notably, junctions of HBV X gene with
retrotransposon sequences, such as LINE1 and LINE2, became prominent shortly after infection. In woodchucks, insertion of WHV X
and preS sequences into host genome was evident at 1 and 3 h post infection (h.p.i.), conﬁrming that hepadnavirus under natural
conditions integrates into hepatocyte DNA soon after invasion. The HBV and WHV X gene enhancer II/core promotor sequence
most often formed initial junctions with host DNA. Moreover, multiple virus–virus DNA fusions appeared from 1 h.p.i. onwards in
both infected hepatocytes and woodchuck livers. In summary, HBV DNA integrates almost immediately after infection with a variety
of host’s sequences, among which tandemly repeating non-coding DNAs are common. This study revealed that HBV can engage
mobile genetic elements from the beginning of infection to induce pro-oncogenic perturbations throughout the host genome.
Such swift virus insertion was also evident in natural hepadnaviral infection in woodchucks.
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INTRODUCTION
Hepatitis B virus (HBV) is a pro-oncogenic virus and chronic HBV
infection is the main cause of primary hepatocellular carcinoma
(HCC) with attributed 780 thousand deaths annually worldwide.1,2
HBV carcinogenesis have been directly linked to the transforming
properties of the virus X and truncated preS-S proteins and, in
particular, to integration of viral DNA altering the host’s genome
stability and expression of individual genes.3–5 The integration of
HBV X (HBx) and S gene sequences had been commonly observed
in HBV-associated HCC and the prevailing opinion was that the
virus insertions are random throughout the liver genome. More
recent high-throughput studies however indicated that certain
genomic sites are more frequently targeted for HBV integration
than others.6–8 Fusion of HBx with retrotransposon LINE1
(long-interspersed nuclear element-1 or L1) and the resulting
HBx-LINE1 chimeric non-coding RNA transcripts were found in
a signiﬁcant portion of HBV-positive HCCs and coincided with
a decreased survival of the patients.9 These chimeric transcripts
display tumor promoting properties and may foster liver injury by
sequestering hepatocellular microRNA-122.9,10 It might also be
that fusion of viral DNA with LINE1 may spread viral genetic
material across the host’s genome owing to the intrinsic mobility
of this retrotransposon.11,12
The direct oncogenic role of HBV is most perceptible in HCC
developing in the absence of chronic hepatitis, as in persons with
asymptomatic occult HBV infection who carry HBV DNA in the
absence of serum HBV surface antigen.13–15 This also is evident in
the woodchuck model that closely mimics molecular and
pathogenic events in HBV-infected humans.16,17 In primary occult
infection caused by very small amounts of woodchuck hepatitis
virus (WHV), HCC develops in the context of normal liver histology,
whereas the liver and immune system carry integrated WHV
DNA.18 HCC also arises at a similar frequency (~20%) after acute
hepatitis followed by WHV DNA-positive, virus surface antigen-
negative infection, termed as secondary occult infection.16,19 For
comparison, the majority (~80%) of WHV DNA-positive, virus
surface antigen-positive animals with chronic hepatitis develop
HCC, indicating that in the context of protracted virus replication
chronic inﬂammation augments HCC development.16,20,21
Dissection of the earliest events in HBV infection has been
hampered by the lack of in vitro infection models. However, with
the recent establishment of human hepatocyte-compatible
cultures, such studies became feasible.22,23 In our study, exploring
HepaRG cells susceptible to authentic HBV and the woodchuck–
WHV infection model, we determined the time of the appearance
and the initial sites of hepadnavirus integration, and the proﬁle of
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virus insertional sites across chromosomes shortly after infection.
The characteristics of these very early events were unknown
before but they can be critical to hepatocyte pro-oncogenic
perturbations and virus lifelong persistence.
RESULTS
Early hepadnaviral infection proﬁles in HepaRG cells and
woodchucks
Differentiated HepaRG cells were exposed to HBV in plasma from
treatment-naive patients NL01.A, NL02.C and NL03.E with chronic
hepatitis B (Table 1). The cells became HBV DNA reactive from 1 h
post infection (h.p.i.) at 1.8 × 103 ± 5.7 × 102 copies or virus
genome equivalents (vge)/μg DNA (see Figure 1a). The virus
achieved 8.8 × 103 ± 1× 103 vge/μg DNA at 1 and 2 weeks post
infection (w.p.i.), and then declined until 7 w.p.i. Cells infected
with NL03.E were positive at 9.5 × 103 ± 1.4 × 103 vge/μg DNA
at 1 and 2 w.p.i. At 14 d.p.i., HBV surface antigens were detected in
~ 15% of the cells by immunoﬂuorescent staining. HBV transcripts
were identiﬁed 1 h post exposure onward. HBV covalently closed
circular DNA (cccDNA) became detectable from 3 d.p.i. with HBV
NL01.A and NL02.C, up to 7 w.p.i. Detection of HBV RNA earlier
than cccDNA was likely due to a 100-fold greater sensitivity of the
HBV RNA detection assay.18,24 The time-dependent kinetics of HBV
infection were overall comparable to those reported before;22,25,26
however, perhaps because of the earlier time points tested and
more sensitive polymerase chain reaction/nucleic acid hybridiza-
tion (PCR/NAH) assays used,18,19,27 HBV DNA and its replication
were detected earlier. HBV infection was not detected in HepaRG
exposed to HBV for less than 1 h or after mock infection with
normal human plasma (NHP).
In woodchucks, WHV DNA was detected in liver biopsies (Lbx)
obtained at 1 or 3 h.p.i. (Lbx-2) and at 6 w.p.i. (Lbx-3) (see Figure 1b),
as reported.24 WHV DNA levels were 1× 105± 1×102 vge/μg DNA in
Lbx-2 and 1×108 ±1×103 vge/μg DNA in Lbx-3 samples.
Liver tissue acquired prior to inoculation (Lbx-1) were WHV DNA
non-reactive. WHV mRNA was identiﬁed in LBx-2 and LBx-3,
whereas WHV cccDNA in LBx-3 samples.24
Inv-PCR combined with NAH enhances detection of
hepadnavirus–host junctions
HBV–host DNA junctions were detected by inverse-PCR (invPCR)
essentially as reported.28 As invPCR occasionally generated
products that did not contain detectable integrants after clonal
sequencing, probing of the amplicons for viral DNA by NAH was
implemented (Supplementary Figure 1). Consequently, only the
NAH-positive amplicons were clonally sequenced. Ultimately, only
virus–host fusions conﬁrmed by sequencing were accepted. This
stringent approach led to identiﬁcation of HBV integrations from
1 h.p.i. to 7 w.p.i. in HepaRG exposed to HBV NL01.A (Figure 1a and
Supplementary Figure 1). In the NL02.C-treated cells, the signals
were also detected after 1-h outwards, whereas in those with
NL03.E at 1 and 2 w.p.i. (Figure 1a). There were no NAH signals
after invPCR of DNA from HepaRG collected at time zero or
exposed to NL01.A or NL02.C for less an hour (Figure 1a) or
to NHP.
Hybridization signals implying WHV–host junctions were
detected in Lbx-2 from three woodchucks and in LBx-3 from all
four animals (Figure 1b). Lbx-1 samples were non-reactive
(Figure 1b).
Hepadnavirus–host genome integration after de novo infection
Meticulous analysis of the virus–host junctions was performed. The
coordinates of virus integrants and the right-side ﬂanking host
sequences, HBV inoculum used, and the time at which each
integration was detected are identiﬁed in Table 2 and their
sequence GenBank accession numbers are listed in Supplementary
Table 1. Overall, there were 22 unique integration sites detected of
Table 1. Virological characteristics of patients with chronic hepatitis B who provided HBV inocula
Inoculum Patient age (years)/sex HBV DNA(IU/ml)a HBV genotypeb HBsAgc HBeAgc Anti-HBec Anti-HBcc HIV RNAd Anti-HCVe
NL01 58/M 2.7 × 107 A pos pos neg pos neg neg
NL02 35/F 1.1 × 108 C pos n.a. n.a. pos neg neg
NL03 33/M 5.8 × 108 E pos pos n.a. pos neg neg
Abbreviations: anti-HBc, antibodies to HBV core antigen; anti-HBe, antibodies to HBeAg; anti-HCV, antibodies to hepatitis C virus; F, female; HBeAg, HBV e antigen;
HBsAg, HBV surface antigen; IU, international units; M, Male; n.a., not available. aDetermined by COBAS Ampliprep/TaqMan HBV Test (sensitivity 20 IU/ml) Roche
Diagnostics, Laval, Quebec, Canada. bAssayed by in-house PCR with HBV S gene-speciﬁc primers (forward primer: 5′-GCCTCATTTTGTGGGTCACCATA-3' and reverse
primer: 5′-ATAACTGAAAGCCAAACAGTGGG-3') and bidirectional sequencing of the resulting 1115-bp amplicons. cDetermined by ARCHITECT immunoassays from
Abbott Diagnostics, Mississauga, Ontario, Canada. dTested by Abbott Real Time HIV-1 assay m2000 (sensitivity 75–107 virus copies/ml), Abbot Diagnostics,
Mississauga, Ontario, Canada. eDetermined by COBAS Amplicor HCV v2.0 (sensitivity 50–60 IU/ml), Roche Diagnostics, Laval, Quebec, Canada.
Figure 1. Study design and detection of HBV DNA- or WHV
DNA-speciﬁc signals by invPCR/NAH after infection of HepaRG cells
or healthy woodchucks. (a) HepaRG cells infected with authentic
HBV from patients NL01.A, NL02.C and NL03.E with chronic
hepatitis B. (b) Woodchucks Cw1 to Cw4 intravenously infected
with WHVtm/3 inoculum. Liver biopsy 1 (Bx-1) obtained prior
to experiment, LBx-2 at 1 or 3 h after injection with WHV, and LBx-3
acquired 6 weeks thereafter. Open circles show the acquisition time
of cells or liver biopsies and closed circles represent samples in
which virus DNA hybridization signals suggesting virus–host
integration were detected. A, C and E, HBV genotypes; F, female;
M, male.
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Table 2. HBV-human genome junctions identiﬁed after de novo infection
HBV inoculum/
time post
infection
Total of virus–host
junctions detected
(no)
Integrated HBV
sequence (nt.
position)
Host
sequence
(bp length)
Chromosome
number
Sequence
locus
Host sequence
(nt. position)
Gene Total of virus–
virus junctions
detected (no)
NL01.A
1 h 4 1720–1603 17 1 q21.1 420–437 ANP32E 0
1639–1829 18 7 q22.1 98457063–98457081 S3A-26
1647–1720 40 10 q21.2 111339527–111339567 ANK3
1662–1603 48 13 q33.1 102521074 102521122 FGF14
3 h 2 1645–1700 27 14 q32.3 54–27 UI 14
1603–1624 204 14 q31.3 86038392–86038596 FLRT2/L2
24 h 4 1246–1390 20 1 p21.3 97732036–97732056 DPYD 3
1370–1423 16 7 q36.1 60109931–60109947 RNY-1
1603–1623 141 8 p23.1 7874512–7874653 L1
1603–1624 204 14 q31.3 86038392–86038596 FLRT2/L2
3 d 6 1371–1390 244 10 q11.21 42599732–42599976 HSAT-II 3
1647–1818 505 11 q13.4 71034849–71034344 L2
1647–1818 502 11 q13.4 71034849–71034347 L2
1647–1818 505 11 q13.4 71034849–71034344 L2
1647–1818 544 11 q13.4 71034849–71034305 L2
1603–1624 204 14 q31.3 86038392–86038596 FLRT2/L2
1 w 5 1647–1818 268 11 q13.4 71034849–71034581 L2 12
1647–1818 496 11 q13.4 71034849–71034353 L2
1647–1818 254 11 q13.4 71034849–71034595 L2
1634–1818 302 11 q13.4 71034849–71034547 L2
1634–1818 502 11 q13.4 71034849–71034347 L2
2 w 10 1603–1664 19 1 q31.3 194161891–194161910 eEF1AP14 7
1623–1717 151 2 q31.1 171450967–171450816 Myo3B
1638–1717 151 2 q31.1 171450967–171450816 Myo3B
1645–1717 188 2 q31.1 171450967–171450779 Myo3B
1623–1717 160 2 q31.1 171450967–171450,807 Myo3B
1622–1717 167 2 q31.1 171450967–171450800 Myo3B
1638–1717 220 2 q33.1 2000084860–200085080 RNU7–147 P
1276–1389 59 2 q33.1 200085021–200085080 RNU7–147 P
1638–1784 44 9 q22.3 99607513–99607557 ZNF782
1642–1784 57 9 q22.3 99607513–99607570 ZNF782
4 w 11 1634–1717 188 2 q31.1 171450967–171450779 Myo3B 5
1633–1717 188 2 q31.1 171450967–171450779 Myo3B
1633–1717 188 2 q31.1 171450967–171450779 Myo3B
1634–1717 188 2 q31.1 171450967–171450779 Myo3B
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1645–1784 90 9 q22.33 99607513–99607603 ZNF782
1668–1808 276 10 q21.3 70434086–70434362 TET1
7 w 3 1634–1826 32 2 q37.1 235357695–235357727 RPS20P12 7
1643–1826 35 8 p23.1 96050–96085 AC144568
1645–1739 60 10 p11.23 28765451–28765521 WAC-AS1
NL02.C
1 h 8 1616–1659 120 11 q25 131410505–131410385 NTM 11
1606–1659 125 11 q25 131410505–131410380 NTM
1606–1659 125 11 q25 131410505–131410380 NTM
1624–1659 120 11 q25 131410505–131410385 NTM
1606–1659 113 11 q25 131410505–131410392 NTM
1606–1659 116 11 q25 131410505–131410389 NTM
1606–1659 135 11 q25 131410505–131410370 NTM
1606–1659 151 11 q25 131410505–131410354 NTM
24 h 6 1645–1764 274 15 q11.2 21340909–21341183 L1 0
1645–1764 274 15 q11.2 21340909–21341183 L1
1645–1764 274 15 q11.2 21340909–21341183 L1
1645–1764 274 15 q11.2 21340909–21341183 L1
1645–1764 274 15 q11.2 21340909–21341183 L1
1645–1764 274 15 q11.2 21340909–21341183 L1
3 d 2 1625–1606 215 8 p23.1 7441825–7442040 L1 4
1624–1603 189 8 p23.1 7150697–7150886 L1
2 w 2 1716–1780 79 1 p2.1 148552682–148552761 NBPF25P 2
1390–1388 208 5 q13.3 76373689–76373809 ZBED3
NL03.E
7 d 1 1641–1778 271 10 q21.3 146–417 S3A-37 2
2 w 12 1647–1826 33 16 p11.2 34456932–34456965 HSAT-II 1
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which 14 were single hits and 8 multiple hits of the same sites. To
streamline presentation, the junctions found up to 24 h.p.i. were
classiﬁed as very early integration sites (VEIS), between 3 and
7 d.p.i. as early integration sites (EIS), and at 2 w.p.i. and onwards as
late or not-early integration sites (NEIS). There were 9 sites identiﬁed
as VEIS, 5 as EIS (with two also categorized as VEIS), and 11 as NEIS
(with one also classiﬁed as EIS) (Table 2). Comparing
a number of clones carrying the particular class of integrations
with the total number of clones with virus–host junctions detected
(n=76), VEIS represented one-third (31.6%), EIS one-ﬁfth (18.4%),
and NEIS a half (50%) of the clones. This suggested an increase in
HBV integration events over the time examined.
WHV–host junctions discovered in woodchuck livers are
presented in Table 3 and their sequence GenBank accession
numbers in Supplementary Table 2. There were 10 VEIS identiﬁed
in Lbx-2 collected at 1 or 3 h.p.i. and 7 classiﬁed as NEIS in Lbx-3
acquired at 6 w.p.i.
The initial sites of HBV integration into human genome
The formation of the earliest integration sites or VEIS was
examined after HepaRG exposure to HBV N01.A or N02.C
(Figure 1a). The ﬁrst junctions were apparent after 1 h exposure.
HBV N01.A produced multiple single site hits, whereas HBV N02.C
formed a junction with the single site identiﬁed in all (8/8) clones
caring integrations at this time point (Table 2). The site was within
neurotrimin gene at chromosome (Ch) 11q25. It formed four-base
pair (bp) overlapping homologous junction and had AAGA
sequence created by nucleotides (nts) 1656–1659 of HBx and
nts 131 410 505–131 410 502 of Ch11 (Figure 2 and Table 2). After
24-h exposure, HBV N02.C formed a junction with retrotransposon
LINE1 located at Ch15q11.2 apparent in six clones. This was the
head-to-tail join (HTJ) of HBx at nt 1764 with nt 21 340 909 of
Ch15q11.2 (Figure 3). The VEIS involving LINE1 was also detected
after 24-h exposure to NL01.A, but the LINE1 sequence engaged
was located at Ch8p23.1 (Table 2). HBV NL01.A after 3 and 24-h
exposure, and also at 3 d.p.i., formed a junction with the FLRT2
gene which the C-terminal sequence was joined with another
retrotransposon, long-interspersed nuclear element-2 (LINE2 or
L2) (Supplementary Figure 2). Interestingly, although these three
integrations occurred at different time post infection, all formed
HTJ with FLRT2 that was fused with LINE2 and all were located
on Ch14q31.3.
The early HBV–host DNA integrations
The EIS were deﬁned as those forming junctions at 3 and 7 d.p.i.
Thus, infection with HBV NL01.A produced at both time points
integration with LINE2 evident in nine clones (Table 2). HBV-LINE2
fusion was of overlapping homologous junction type with the
sequence AGCACCATGCA created by nts 1808–1818 of HBx and
nts 71 034 849–71 034 839 of Ch11q13.4 (Figure 4). Also, a singular
junction of HBV NL01.A with human satellite II DNA (HSAT-II) was
identiﬁed at 3 d.p.i (Table 2). Regarding NL02.C, virus junctions
with LINE1 were identiﬁed at 3 d.p.i. in two different locations on
Ch8p23.1 (Table 2). NL02.C did not generate detectable integra-
tion signal at 7 d.p.i. (Figure 1a).
Characteristics of the late HBV–host genome fusions
From 2 w.p.i. onward, HBV was found integrated at several sites
(Table 2). One of the most prominent NEIS at 2 and 4 w.p.i. with
HBV NL01.A was myosin III B at Ch2q31.1. This junction was the
eight- bp overlapping homologous junction with sequence
AAGAGCTG created by overlapping nts 1770–1717 of HBx and
nts 171 450 967–171 450 960 of Ch2q31.1, and was conﬁrmed in
nine clones (Figure 5). Another prominent site was at gene
encoding zinc ﬁnger protein 782 (ZNF782) on Ch9q22.3 forming
the HTJ-type bond between HBx of HBV NL01.A at nt 1784 and nt
99 607 513 of Ch9q22.3 (Figure 6). Infection with NL03.E led to
formation of yet another prominent junction with a tandemly
repeating non-coding DNA, HSAT-II, located on Ch16p11.2. This
HTJ was formed by HBx nt 1826 and nt 34 456 932 of Ch16p11.2
and was detected in 12 clones at 2 w.p.i. (Figure 7). As mentioned,
a single hit at HSAT-II on Ch10q11.21 was also identiﬁed as an EIS
after infection with NL01.A (Table 2).
In addition, there were several NEIS detected in singular clones,
including: eEF1AP14 on Ch1q31.3 (Table 2), RNU7-147B on Ch2q33.1
(Table 2), ZBED3 on Ch5q13.3 (Supplementary Figure 3A), AC144568
on Ch8p23.1 (Table 2), and TET1 on Ch10q21.3 (Supplementary
Figure 3B). All of them were HTJ with HBx.
WHV–host DNA integrations
Three woodchucks showed WHV-speciﬁc signals after invPCR/NAH
in liver biopsies collected at 1 or 3 h.p.i. (Figure 1b). These were
integrations of the X gene (WHx) or preS region (WHpS), as
veriﬁed by clonal sequencing. Several VEIS were identiﬁed
(Table 3). The most prominent was that detected in Lbx-2 from
Table 2. (Continued )
HBV inoculum/
time post
infection
Total of virus–host
junctions detected
(no)
Integrated HBV
sequence (nt.
position)
Host
sequence
(bp length)
Chromosome
number
Sequence
locus
Host sequence
(nt. position)
Gene Total of virus–
virus junctions
detected (no)
1659–1826 35 16 p11.2 34456932–34456967 HSAT-II
1646–1826 39 16 p11.2 34456932–34456971 HSAT-II
1647–1816 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 35 16 p11.2 34456932–34456967 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
1647–1826 34 16 p11.2 34456932–3445696 HSAT-II
1647–1826 34 16 p11.2 34456932–34456966 HSAT-II
Abbreviations: AC144568, uncharacterized RNA gene; ANK3, ankyrin3; ANP32E, acidic (leucine rich) nuclear phosphoprotein 32 family, member E; DPYD,
dihydropyrimidine dehydrogenase; eEF1AP14, eukaryotic elongation factor 1 ribosomal protein; FGF14, ﬁbroblast growth factor 14; FLRT2, ﬁbronectin leucine
rich transmembrane protein; HSAT-II, human satellite II DNA; L1, long-interspersed nuclear element-1; L2, long-interspersed nuclear element-2; Myo3B, myosin
III B; NTM, neurotrimin; NBPF25P, neuroblastma breakpoint family member 25 pseudogene; RNU7-147P, RNA U7 small nuclear 147 pseudogene; RNY-1,
Ro-associated Y pseudogene 1; RPS20P12, ribosomal protein S20 pseudogene 12; S3A-26, ribosomal protein S3A pseudogene 26; S3A-37, ribosomal protein
S3A pseudogene 37; TET1, ten-eleven translocation 1 gene; UI, unidentiﬁed sequence; WAC-AS1, WAC antisense RNA gene; ZBED3, zinc ﬁnger, BED-type
containing 3; ZNF782, zinc ﬁnger protein 782.
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Cw4/M, but the gene could not be assigned due to limited
woodchuck sequence recognition. In two clones, WHx integrated
at AAK1 gene on Ch2q14, based on480% homology with human
sequence (Table 3). Other VEIS were located at MAML2, KIA1117,
PHACTR3 and LPIN3 genes. All of them formed HTJ with WHpS or
WHx. Junctions were also identiﬁed in Lbx-3 samples acquired
at 6 w.p.i. However, except for the HDAC-9 gene, their human
equivalents could not be identiﬁed (Table 3). Identiﬁcation of
another site, NLRC5, was based on compatibility with the mouse
genome. WHV integrations with MAML2, PHACTR3 and NLRC5 are
shown in Supplementary Figure 4. Overall, this investigation
conﬁrmed that WHV, similar to HBV, integrates into host genome
almost immediately after infection.
In addition, multiple virus–virus junctions were identiﬁed after
infection with HBV or WHV (Tables 2 and 3). Although they were
not the subject of this study, their existence at very early stages
was consistent with detection of virus–host integrations and may
suggest that similar mechanisms underlined their formation.
Mapping of hepadnavirus X gene breaking points forming
virus–host junctions
Most of the HBV–host junctions were formed by the HBx gene
encompassing the core promoter (CP)/Enh-II region between nts
1613 and 1829 (Figure 8). Within this sequence, 75% (18/24) of all
HBx breaking points were found, corresponding to 88.3% (68/77)
of all hits. Further, 6/24 (25%; 22 hits), classiﬁed as cluster-1 (C1)
(Figure 8), were conﬁned to Enh-II, whereas 10/24 (40.6%; 42 hits)
to basic core promoter (BCP). This clearly showed that the HBV
BCP sequence was most prone to form junctions with host
genome. The breaking points in the BCP were further divided into
two clusters, C2 and C3 (Figure 8). The C2 spanned nts 1764–1808
that contained the TATA-like binding sequences (TA2–TA4) within
nts 1758–1795, as well as pre-core mRNA initiation sites at nts
1788–1795. Six breaking points were identiﬁed in this region,
including one with six hits at position 1764. The C3, encompassing
nts 1816–1829, contains the HBV pre-genomic RNA initiation site
at nt 1818.29 Four breaking points were found in this sequence,
including one with nine hits at the initiation site.
Considering WHx, the junctions were predominantly located
between nts 1810–1877 (10 hits at six sites), corresponding to the
WHV BCP region. The preS breaking points were located within nts
3250–3308 (Table 3).
Distribution of hepadnavirus–host integration sites identiﬁed in
this study across human chromosomes is shown in Supplementary
Figure 5.
DISCUSSION
Integration of HBV DNA into hepatocyte genome has long been
considered as the main contributor to liver oncogenesis and
a potential determinant of virus persistence; however the timing
of initiation of this process and the proﬁle of virus insertional sites
soon after infection remained unknown. In this study, we showed
that HBV and its close relative WHV can integrate into host
genome very soon after virus invasion, at the time of or shortly
before viral replication became apparent in both infection models.
Previously, supercoiled DNA of duck hepatitis B virus was
identiﬁed as early as 6 h.p.i. and virus RNA transcripts at 12 h.p.i.
in duckling livers by classical nucleic acid hybridization of
relatively low sensitivity,30 whereas duck hepatitis B virus cccDNA
from 9 h.p.i. in duck hepatocytes by PCR.31 The earliest HBV DNA
integration was reported in hepatoma Huh7 cells at 8 d.p.i. by
classical Southern blot analysis.32 In our study, the use of high
sensitivity detection approaches and the cells from several
minutes post exposure onwards shortened the time between
the ﬁrst contact with virus and identiﬁcation of its replication and
integration. This resembles the dynamics of HIV type 1 infection in
cultured CD4+ T cells where viral reverse transcription occurred
within 3 h.p.i. and virus integration at 8.5 h.p.i. as evaluated by
quantitative PCR.33 The utilization of end-point PCR followed by
NAH, which further enhanced sensitivity,18,19,27 was likely a reason
behind our earlier detection of virus integrational signals.
To identify the initial sites of integration and their proﬁles across
chromosomes, time-course experiments with authentic HBV were
performed. The host sequences identiﬁed as the initial insertional
sites were deﬁned as those detected between 1 and 24 h after
contact with virus. In the case of HBV, there appeared to be two
proﬁles of virus integration. Thus, although infection with HBV
NL01.A yielded junctions with several genes detectable in singular
clones (Table 2), HBV NL02.C produced fusions with only two sites
robustly presented in multiple clones. One of these sites was
neurotrimin (Figure 2) encoding a neural adhesion molecule also
occurring in stem and hepatic stellate cells,34 whereas another
retrotransposon LINE1 (Figure 3). As all experimental and
analytical conditions were identical, the difference might be
related to the virus alone. Notably, these two inocula carried
Table 3. WHV–woodchuck genome junctions identiﬁed in liver biopsies after de novo infection
Animal/ liver biopsy
number
Total of virus–host
junctions detected (no)
WHV sequence
(nt. position)
Host sequence
(bp length)
Chromosome
numbera
Sequence
locusa
Host sequence
(nt. position)
Genea Total of virus–virus
junctions detected (no)
Cw1/M LBx2-1 h.p.i. 3 PS3200–3256 33 11 q21 95720503–95720470 MAML2 3
X1853–1876 16 UI UI UI UI
PS2785–2934 36 15 q25 84783482–84783518 EFTUD1P1
Cw2/F LBx2-1 h.p.i. 5 X1913–1853 48 2 p14 69870009–69870057 AAK1 12
X1913–1853 118 2 p14 69784039–69784157 AAK1
X1913–1853 19 6 q14.1 83777393–8377412 KIAA1117
X1910–1853 20 20 q12 39989149–39989169 LPIN3
PS3030–3009 17 20 q13.2 178193731–178193748 PHACTR3
Cw4/M LBx2–3 h.p.i. 3 PS3250–3308 75 UI UI UI UI 4
PS3251–3308 68 UI UI UI UI
PS3251–3308 70 UI UI UI UI
Cw1/M LBx3–6 w.p.i. 2 X1855–1876 16 UI UI UI UI 0
X1854–1877 18 16b q13b 2650–2632 NLRC5b 0
Cw2/F LBx3–6 w.p.i. 2 X1623–1501 210 UI UI UI UI 0
X1548–1501 137 UI UI UI UI
Cw3/F Bx3–6 w.p.i. 1 X1772–1821 81 UI UI UI UI 2
Cw4/M LBx3–6 w.p.i. 2 PS3250–3308 68 UI UI UI UI 4
X1651–1810 26 X p21.1 18674290–18674316 HDAC-9
Abbreviations: AAK1, AP-1 associated kinase; EFTUD1P1, elongation factor Tu GTP binding domain containing 1 pseudogene; HDAC-9, histone deacetylase-9;
Kazusa cDNA 1117; KIAA1117; LPIN3, lipin-3; MAML2, mastermind-like 2; NLRC5, NLR family CARD domain containing 5; PHACTR3, phosphatase and actin
regulator 3; UI, unidentiﬁed sequence. aBased on homology with human genome. bBased on homology with mouse genome.
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different HBV genotypes, A and C. In liver biopsies obtained at 1 or
3 h.p.i. from woodchucks infected with the same virus, WHV
formed junctions with multiple genes localized on different
chromosomes. This provided valuable conﬁrmation that authentic
hepadnavirus under natural in vivo infection conditions integrates
within the same time frame as in our in vitro model and suggested
that the initial integration at multiple rather than singular sites is
the prevailing mode of hepadnavirus insertion. Undoubtedly,
further studies will be required to determine potential inﬂuence of
virus genotype on its insertional proﬁle and if distinct integration
Figure 2. HBV integration with the neurotrimin (NTM) gene in HepaRG cells after 1-h exposure to NL02.C inoculum. (a) Schematic presentation
of integration of HBx sequence (continuous lines) with NTM (shaded boxes) detected in eight separate clones (1–8). All clones displayed the
same four-bp overlapping homolgous virus–host junction. Locations of the junction in Ch11q25 and in relation to the HBx sequence are
shown. (b) Sequencing electropherograms depict in detail the nucleotides forming the OHJ. HBV and NTM sequences are marked by
continuous and dashed lines, respectively. Enh-II, HBV enhancer II; DR1, direct repeat 1.
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patterns may coincide with different infection outcomes, includ-
ing HCC development. The woodchuck–WHV model is in an
advantageous position to advance our understanding of this and
related issues.
In the period between 3 and 7 d.p.i., the HBV insertional sites,
designated as EIS, almost exclusively encompassed LINE1 and
LINE2 sequences represented in multiple clones (Table 2 and
Figure 4). In addition, singular clones carrying HBV junctions with
HSAT-II or FLRT2-L2 were detected after infection with HBV NL01.A
(Table 2). Interestingly, in this last case, although virus integrated
with FLRT2 gene, FLRT2 was also fused with a LINE2 sequence.
This FLRT2-L2 merge was located 124-nt upstream from the
HBV-FLRT2 junction (Supplementary Figure 2). This was validated
by detection of the same HBV-FLTR2-L2 sequence at three
different time points, that is, 3 and 24 h.p.i. and 3 d.p.i. (Table 2
and Supplementary Figure 2). In this regard, complex fusions
and gene rearrangements were previously reported in the
proximity to HBV DNA inserts.9,35,36 The function of FLTR2 is not
deﬁned but it is implicated in embryogenesis, organogenesis, and
ﬁbrogenesis.37 Dysregulation of genes involved in these processes
have been linked to cancer development. The makeup of the HBx-
FLRT2-L2 chimera may suggest a role in liver oncogenesis.
In the late post infection phase, multiple integration sites,
classiﬁed as NEIS, were uncovered. Among them, HSAT-II had most
Figure 3. HBV DNA integration with LINE1 (L1) after 24-h exposure to HBV NL02.C. (a) Schemes showing HBx (continuous lines) integrated
with LINE1 (shaded boxes) found in six independent clones (1–6). All clones demonstrated the same sequence of the head- to-tail junction.
Location of the junction in Ch15 at q11.2 and in relation to HBx sequence are shown. (b) Electropherograms detailing the breaking point
between HBV (continuous line) and LINE1 (dashed line). See the legend to Figure 2 for more details.
Initial hepadnavirus–host genome interaction
R Chauhan et al
7
Oncogenesis (2017), 1 – 14
hits (Table 2 and Figure 7). HBV integration at HSAT-II has not been
reported, although HBV fusion with a related HSATIII was
described in a hepatoma cell line and in tissues from HCC
patients.38,39 Another NEIS with frequent hits was the myosin III B
gene at Ch2q31.1 (Figure 5), which encodes one of the
actin-activated class III ATPses also occurring in hepatocytes.40
Frequent hits were also found with the ZNF782 (Figure 6) that
encodes a nuclear DNA-binding protein likely functioning as
a transcriptional factor.41 In liver biopsies from woodchucks at
6 w.p.i., WHV DNA was integrated at several genes and these
insertions were largely in singular clones (Table 3).
One of the potentially most important ﬁndings was that
HBV from the earliest stages of infection can integrate with
retrotransposable elements, such as LINE1 and LINE2, and also
HSAT-II. Considering the total number of insertional hits, almost
a half (45.3%) were junctures with one of these sequences. This is
in general agreement with recent studies showing that many HBV
insertions occur in or near repetitive non-coding sequences, such
as LINE, short interspersed nuclear elements and Alu.7–9,42 Our
ﬁnding of HBV integration with LINE retrotransposons, especially
with LINE1, is particularly interesting. Human LINE1 is recognized
as a major endogenous mutagen, a crucial source of mutations in
HCC, and a mobile genetic element able to relocate sequences to
new loci across chromosomes.11,12,43 Recent studies also uncov-
ered that HBx-LINE1 integrants occur in a signiﬁcant number of
HBV-positive HCC and demonstrated pro-oncogenic properties of
chimeric RNA transcribed from HBx-LINE1 fusion.9,10,44 HBx-LINE1
transcripts were shown to activate oncogenic β-catenin/Wnt
signaling, promote epithelial–mesenchymal transition of
hepatocytes,9 and sequester hepatocellular miR-122 fostering
tumorigenic changes and liver tissue injury.10 Considering these
properties of LINE1 and pro-oncogenic attributes of HBx-LINE1
Figure 4. HBV integration with transposon LINE2 (L2) at 3 and 7 days post infection of HepaRG cells with NL01.A. (a) Integration of HBx
(continuous lines) with LINE2 (shaded boxes) detected in four clones (1–4) obtained after 3 d.p.i. and in ﬁve clones (1–5) acquired at
7 d.p.i. (1–5). Different lengths of the LINE2 sequences identiﬁed, details on the HBV and LINE2 nucleotides forming the 11-bp homologous
junction, except a singular nucleotide mismatch (T versus G), and location of the junction in relation to the HBx sequence and Ch11q13.4 are
presented. (b) Electropherograms showing details on the contributions of HBV (continuous line) and LINE2 (dashed line) nucleotides to
formation of the OHJ.
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transcripts, the ﬁnding of HBx-LINE1 integration very early after
contact with virus implies that some of the processes begin to
operate almost immediately after infection. This may also suggest
that the molecular cascade of pro-oncogenic events could persist
in the cell affected and its progeny long after resolution of
hepatitis and during clinically silent infection, such as in occult
infection preceding development of HCC.13–15,18,19,45
HBx also formed junctions with retrotransposon LINE2 and
another repetitive sequence, HSAT-II, but relevance of these
interactions remain obscure. A role of HSAT-II derepression
coinciding with overexpression of LINE1 was recently emphasized
in the oncogenesis of epithelial cancers.46,47 The postulated
mechanism of upregulated HSAT-II expression in human
carcinomas assumes a global dysregulation in DNA methylation,
which is critical for the satellite repression.46,48 Whether HBx-
HASTII fusion may modify normally silenced HASTII has yet to be
examined.
Our study also aimed at the delineation of integration break-
points in HBV and WHV X gene, as this gene consistently
demonstrated the greatest propensity to form virus–host
junctures. Most of the HBV breakpoints detected in our study
spanned within the DR regions and were categorized into three
clusters (Figure 8). C1 was located within the Enh-II sequence,
suggesting that the enhancer may hijack the transcriptional
control of the fused host genes and involve them in liver
pathogenic and tumorigenic perturbations. Also, as Enh-II can
Figure 5. HBV integration with myosin III B (Myo3B) encoding gene in HepaRG cells at 2 and 4 weeks post infection with NL01.A.
(a) Schematic presentation of integration of HBx sequence (continuous lines) with Myo3B (shaded boxes) detected in ﬁve (1–5) and four (1–4)
clones obtained at 2 and 4 w.p.i., respectively. Different lengths of the Myo3 sequences, HBV and Myo3B nucleotides forming the eight-bp
OHJ, and location of the integration in Ch11q13.1 and within the HBx sequence are shown. (b) Electropherograms detailing nucleotides
forming the junction in relation to sequences of HBV (continuous line) and Myo3B (dashed line).
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enhance expression of the downstream genes,49 the Enh-II fusions
may modulate transcription of the genes not only directly linked
but also those situated in the proximity of the junctions. C2 and C3
were located within nts 1764–1808 and 1816–1829, respectively,
which span BCP (Figure 8). BCP has a central role in directing the
transcriptional initiation of viral pre-core and pre-genomic
mRNAs.50 Within the BCP region, there are four TATA box-like
TA elements. TA1–TA3 are required for the optimal transcription of
pre-core mRNA, whereas TA4 initiates downstream transcription of
pre-genomic mRNA.51 HBx breakpoints within C2 and C3 may
reduce or selectively abrogate transcription of viral RNA but they
may also augment expression of the joined host sequences. Since
virus–host integrations are common in HCC developing in the
context of hepadnaviral occult infection, coinciding with very low
rates of virus replication,13,18,45 this could be a mechanism uniting
progression of occult infection with HCC development.
In this study, to investigate the initial hepadnavirus–host genome
interactions, we applied: (1) two biologically relevant models of
infection with authentic hepadnaviruses; (2) consecutive sampling
of infected cells or livers beginning from very early time points after
contact with pathogenic virus; (3) highly sensitive and speciﬁc
approaches to detect viral genome integration and (4) detailed
sequence analysis of virus–host junctions. The results demonstrate
that the earliest integration of HBV and WHV occurs almost
immediately after exposure to infectious virus. The results also
showed that although HBV and WHV can form initial junctions with
numerous genes, there is a recognizable trend to create HBx fusions
with retrotransposon sequences. This appears in agreement with
Figure 6. HBV junction with zinc ﬁnger protein 782 (ZNF782) encoding gene in HepaRG cells at 2 and 4 weeks post infection with NL01.A.
(a) Integration of HBx sequence (continuous lines) with ZNF782 gene (shaded boxes) identiﬁed in two clones (1–2) obtained at 2 w.p.i. and in
six clones (1–6) obtained at four w.p.i. Lengths of the ZNF782 sequences identiﬁed, nucleotides of the HBV and ZNF782 HTJ, and location of
the junction in the HBx sequence and Ch11q25 are shown. (b) Electropherograms detailing the junction nucleotides in relation to the HBV
(continuous line) and the ZNF782 (dashed line) sequences.
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the latest ﬁndings in HBV-associated HCC and is of interest in light
of oncogenic properties of HBx-LINE1 chimeric transcripts.
The mechanism of almost immediate hepadnavirus DNA
integration into the host’s genome after infection remains
hypothetical. An intriguing possibility could be a role of the
ribonuclease H domain of hepadnavirus DNA polymerase that
displays at least some properties of HIV integrase.52,53 As this
enzyme activity occurs in intact virions,54 it might facilitate initial
hepadnavirus DNA integration even prior to detectable virus
replication. Another probable mechanism could be very early
activation of DNA repair machinery of double-strand DNA breaks,
which are considered to be the prominent targets of hepadnaviral
integration,55 likely owing to virus induced oxidative stress.56,57
A ﬁnding of signiﬁcantly augmented DNA damage in HepaRG
cells at the time of detection of initial HBV integration might
be consistent with this possibility (Supplementary Figure 6). The
underlying molecular machinery will require meticulous dissection.
In conclusion, our study uncovered that the formation of
virus–host genomic fusions is the very early event in hepadnaviral
infection and that HBV insertions at host sites credited for
Figure 7. HBV DNA integration with retrotransposon human satellite DNA II (HSAT-II) DNA at 2 weeks after infection with NL03.E.
(a) Schematic presentation of HBx (continuous lines) integrated with HSAT-II (shaded boxes) identiﬁed in 12 independent clones (1–12). All
clones demonstrated the same HTJ sequence and locations within Ch16p11.2. (b) Electropherograms show in detail nucleotides forming the
breaking point between HBV (continuous line) and HSAT-II (dashed line).
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important roles in hepatic oncogenesis may take place almost
immediately after infection. In view of this, HBV must be
considered as an unequivocal human carcinogen and that contact
with this virus, including minuscule amounts causing primary
occult infection,16,18,58 has to be utterly avoided.
MATERIALS AND METHODS
HepaRG cell culture and HBV infection
Undifferentiated HepaRG cells (a gift from Dr Camille Sureau, INTS,
Paris, France and purchased from Invitrogen, Burlington, ON, Canada)
tested for mycoplasma were cultivated in Williams E medium with
supplements, as reported.22 For differentiation, 2% DMSO (Sigma-Aldrich,
Oakville, ON, Canada) was added and cells cultured for 2 weeks. For
infection, randomly selected cell cultures (~1.2 × 106 cells/well) were
exposed in duplicate to authentic HBV (Table 1) at a multiplicity of
infection of 20 (~2.4 × 107 DNase-digestion-protected virions) in the
presence of 4% polyethylene glycol-8000. For infection of 24 h or less,
cells were incubated with virus at 37 °C for the indicated time (Figure 1a),
washed, harvested with 0.25% trypsin (Gibco-BRL, Burlington, ON, Canada),
washed, treated with DNase-trypsin-DNase to remove potentially attached
HBV and its DNA,59,60 and nucleic acids extracted.19,60 For infections lasting
longer than 24 h, inoculum was removed after 24 h, and cells were
washed, cultivated for the time speciﬁed (Figure 1a) and treated as above.
Uninfected cells and those exposed to NHP for 24 h and cultured as
infected cells served as controls. For each time point tested, cells from at
least two independent experiments with each HBV inoculum or NHP were
blindly analyzed.
Plasma from three treatment-naive patients with CHB without
co-morbidities served as HBV inocula (Table 1). Patients were negative
for antibodies to hepatitis C virus and HIV type 1 RNA. Plasma from healthy
volunteers served as controls. Samples were collected after study approval
by the Institutional Health Research Ethic Authority and signing written
informed consent.
Woodchucks and WHV infection
Four, 2–3-year old, randomly selected, healthy woodchucks (Marmota monax)
(three males and one female) were intravenously injected with 1.1×1010
virions of WHV/tm3 inoculum (GenBank AY334075), as reported.24 Prior WHV
exposure was excluded by negative testing of sera and liver biopsies obtained
before WHV injection (Figure 1b), as described.18,19,60 LBx-2 were collected at
1 h.p.i. from two animals and at 3 h.p.i. from the remaining two (Figure 1b).
LBx-3 were acquired 6 weeks thereafter from four animals. All woodchucks
became serum WHV DNA-positive, virus surface antigen reactive at 14 d.p.i.
The antigen cleared at 6 w.p.i. in three animals and at 8 w.p.i. in Cw1/M. The
WHV infection status was known prior to this investigation. The animals were
a part of the previous study determining expression of the intrahepatic,
immune response-afﬁliated genes immediately after infection and during
pre-acute and acute phases of WHV hepatitis.24 They were housed in the
Woodchuck Viral Hepatitis Research Facility at Memorial University, St John’s,
NL, Canada. All animal work was approved by the Institutional Committee on
Animal Bioethics and Care.
Detection of HBV and WHV genomes and replication
DNA was isolated as reported.19,60 RNA was extracted with Trizol
(Invitrogen), treated with DNase (Sigma-Aldrich) and reverse transcribed to
cDNA.19,60,61 HBV and WHV DNA were assayed by direct and, if negative,
nested PCR/NAH assays using primers and conditions described
before.18,19,60 For HBV or WHV cccDNA detection assays previously
reported were applied (sensitivity ~ 102 copies/ml).18,62 HBV or WHV RNA
was detected by RT-PCR/NAH (sensitivity o10 copies/ml).18,19,59,61 Viral
DNA or RNA were also quantiﬁed by virus-speciﬁc real-time PCR or RT-PCR
assays.18,61 Mock extractions and nucleic acid preparations from livers of
HBV- or WHV-positive carriers and uninfected HepaRG or normal
woodchuck livers served as controls.18,19,60 NAH analysis was routinely
conducted to verify the speciﬁcity of ampliﬁcation signals, the validity of
controls, and to enhance sensitivity of virus detection.
Detection of hepadnavirus–host genome junctions
HBV–host junctions were identiﬁed by invPCR using conditions reported
with modiﬁcations.28 Hence, HBx-speciﬁc primers were redesigned to
amplify all HBV genotypes by nested PCR. The primers for direct PCR were:
forward (F1) 5′-TTCGCTTCACCTCTGCACGT (1585–1604) and reverse (R1)
5′-5′-AAAGGACGTCCCKCGHAG (1405–1422); and for nested PCR were:
forward (F2) 5′-GTYGCATGGARACCACCGTGA (1603–1623) and reverse (R2)
5′-CACARCCTAGCAGCCATGG (1372–1390) (nt positions according to
GenBank X72702). InvPCR, products were probed by NAH to verify the
presence of virus sequence. Conﬁrmed products were digested with Nco-I
and 10-fold serially diluted digests circularized with T4 DNA ligase, and then
linearized.28 The possibility of self-ligated virus double-stranded DNA was
excluded by digestion with Sph-I. Controls included DNA extracted from
uninfected HepaRG cells, subjected or not to restriction enzyme digestion
and ligation prior to invPCR/NAH, cells exposed to NHP instead of HBV, and
cells exposed to HBV and immediately (time 0) subjected to all procedural
steps. None of the controls showed detectable signals after invPCR/NAH.
Also, DNA from 400 μl of plasma used as HBV or WHV inocula, processed as
cellular DNA, were analyzed and no host sequences were detected.
For identiﬁcation of WHV–host junctions, invPCR with primers speciﬁc
for the WHV X and preS genomic regions was applied, as reported.18 DNA
from Lbx-1, processed in parallel with Lbx-2 and Lbx-3 samples, served as
negative controls. The presence of WHV signals was veriﬁed by NAH.18,19,60
Sequence analysis
HBV sequence coordinates were mapped using BioEdit (Ibis Biosciences,
Carlsbad, CA, USA) and sequences from GenBank as references: X70185
(genotype A), AB033556 (C), and X75657 (E). Human DNA sequences were
identiﬁed and analyzed with NCBI BLAST (National Center for Biotechnology
Information, Bethesda, MD, USA) and mapped for coordinates with BLAST
genome browser (University of California at Sacramento) using human
GRch37/hg19 sequence. WHV DNAs were mapped to the full-length
WHV/tm3 sequence (GenBank AY334075) using BioEdit. Identiﬁcation of
retrotransposable sequences was done using Dfam browser for repetitive
elements and SINEBase for short interspersed sequences.63,64
Figure 8. Schematic representation of the HBV X gene breaking points forming junctions with the human genomic sequences. Slim arrows
identify breaking points which formed junctions detected in single clones, whereas bold arrows represent those identiﬁed in multiple clones.
Four black circles depict HBV TATA elements. BCP, basal core promoter; DR, direct repeat region; Enh-II, HBV enhancer II region; Pg RNA,
pre-genomic RNA; URR, upstream regulatory region. Numbers mark nucleotide positions according to HBV DNA GenBank X70185 sequence.
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